Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1991 Nov;74(3):420–424.

Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.

N Yamamoto 1, S Homma 1, J G Haddad 1, M A Kowalski 1
PMCID: PMC1384634  PMID: 1769691

Abstract

In vitro treatment of peritoneal cells with dodecylglycerol (DDG) in 10% foetal calf serum (FCS) supplemented medium RPMI-1640 results in a greatly enhanced Fc receptor-mediated phagocytic activity of macrophages. This macrophage activation process requires a serum factor in the alpha 2-globulin fraction. When mouse peritoneal cells were treated with 50 ng DDG/ml in a serum-free 0.1% egg albumin-supplemented medium RPMI-1640 (EA medium) for 30 min and cultured in EA medium containing electrophoretically fractionated alpha 2-globulin for 3 hr, a markedly enhanced activation of macrophages was observed. To improve fractionation of alpha 2-globulin, FCS was first precipitated with 50% saturated ammonium sulphate and then the supernatant electrophoretically fractionated. The resultant alpha 2-globulin fraction was unable to support activation of macrophages. Vitamin D3 binding protein (DBP) of the alpha 2-globulin fraction is known to be precipitable by 50% saturated ammonium sulphate. When human alpha 2-globulin was treated with antiserum against human DBP and used in a medium for cultivation of DDG-treated peritoneal cells, no significant activation of macrophages was observed. Cultivation of DDG-treated peritoneal cells in a medium containing a low concentration of purified human DBP (group specific component, Gc) produced a greatly enhanced ingestion activity of macrophages. Purified human Gc protein, when used in an EA medium for step-wise cultivation of DDG-treated B and untreated T cells, was efficiently converted to a macrophage-activating factor.

Full text

PDF
420

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bianco C., Griffin F. M., Jr, Silverstein S. C. Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation. J Exp Med. 1975 Jun 1;141(6):1278–1290. doi: 10.1084/jem.141.6.1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cooke N. E. Rat vitamin D binding protein. Determination of the full-length primary structure from cloned cDNA. J Biol Chem. 1986 Mar 5;261(7):3441–3450. [PubMed] [Google Scholar]
  3. Coppenhaver D. H., Sollenne N. P., Bowman B. H. Post-translational heterogeneity of the human vitamin D-binding protein (group-specific component). Arch Biochem Biophys. 1983 Oct 1;226(1):218–223. doi: 10.1016/0003-9861(83)90287-4. [DOI] [PubMed] [Google Scholar]
  4. Haddad J. G., Kowalski M. A., Sanger J. W. Actin affinity chromatography in the purification of human, avian and other mammalian plasma proteins binding vitamin D and its metabolites (Gc globulins). Biochem J. 1984 Mar 15;218(3):805–810. doi: 10.1042/bj2180805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Homma S., Yamamoto N. Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol. Clin Exp Immunol. 1990 Feb;79(2):307–313. doi: 10.1111/j.1365-2249.1990.tb05195.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Howard B. V., Morris H. P., Bailey J. M. Ether-lipids, -glycerol phosphate dehydrogenase, and growth rate in tumors and cultured cells. Cancer Res. 1972 Jul;32(7):1533–1538. [PubMed] [Google Scholar]
  7. Ngwenya B. Z., Yamamoto N. Activation of peritoneal macrophages by lysophosphatidylcholine. Biochim Biophys Acta. 1985 Mar 29;839(1):9–15. doi: 10.1016/0304-4165(85)90175-8. [DOI] [PubMed] [Google Scholar]
  8. Smith-Gill S. J., Finkelman F. D., Potter M. Plasmacytomas and murine immunoglobulins. Methods Enzymol. 1985;116:121–145. doi: 10.1016/s0076-6879(85)16009-x. [DOI] [PubMed] [Google Scholar]
  9. Van Baelen H., Bouillon R., De Moor P. Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem. 1980 Mar 25;255(6):2270–2272. [PubMed] [Google Scholar]
  10. Yamamoto N., Homma S., Millman I. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J Immunol. 1991 Jul 1;147(1):273–280. [PubMed] [Google Scholar]
  11. Yamamoto N., Ngwenya B. Z. Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids. Cancer Res. 1987 Apr 15;47(8):2008–2013. [PubMed] [Google Scholar]
  12. Yamamoto N., St Claire D. A., Jr, Homma S., Ngwenya B. Z. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues. Cancer Res. 1988 Nov 1;48(21):6044–6049. [PubMed] [Google Scholar]
  13. Yang F., Bergeron J. M., Linehan L. A., Lalley P. A., Sakaguchi A. Y., Bowman B. H. Mapping and conservation of the group-specific component gene in mouse. Genomics. 1990 Aug;7(4):509–516. doi: 10.1016/0888-7543(90)90193-x. [DOI] [PubMed] [Google Scholar]
  14. Zbar B., Tanaka T. Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis. Science. 1971 Apr 16;172(3980):271–273. doi: 10.1126/science.172.3980.271. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES